187 related articles for article (PubMed ID: 12388139)
21. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
[TBL] [Abstract][Full Text] [Related]
22. In nondiabetic, human immunodeficiency virus-infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance.
Haugaard SB; Andersen O; Hansen BR; Andersen UB; Vølund A; Iversen J; Nielsen JO; Madsbad S
Metabolism; 2005 Feb; 54(2):171-9. PubMed ID: 15690310
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels.
Lihn AS; Richelsen B; Pedersen SB; Haugaard SB; Rathje GS; Madsbad S; Andersen O
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1072-80. PubMed ID: 12876073
[TBL] [Abstract][Full Text] [Related]
24. Comparison of dual-energy X-ray absorptiometry machines for measuring fat distribution changes of HIV-associated lipodystrophy.
Yang Y; Zhu WD; Paton NI
Antivir Ther; 2004 Oct; 9(5):771-8. PubMed ID: 15535415
[TBL] [Abstract][Full Text] [Related]
25. Reduction of fat accumulation and lipid disorders by individualized light aerobic training in human immunodeficiency virus infected patients with lipodystrophy and/or dyslipidemia.
Thöni GJ; Fedou C; Brun JF; Fabre J; Renard E; Reynes J; Varray A; Mercier J
Diabetes Metab; 2002 Nov; 28(5):397-404. PubMed ID: 12461477
[TBL] [Abstract][Full Text] [Related]
26. Low-dose growth hormone and human immunodeficiency virus-associated lipodystrophy syndrome: a pilot study.
Andersen O; Haugaard SB; Flyvbjerg A; Andersen UB; Ørskov H; Madsbad S; Nielsen JO; Iversen J
Eur J Clin Invest; 2004 Aug; 34(8):561-8. PubMed ID: 15305891
[TBL] [Abstract][Full Text] [Related]
27. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy.
Sevastianova K; Sutinen J; Kannisto K; Hamsten A; Ristola M; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E85-91. PubMed ID: 18430964
[TBL] [Abstract][Full Text] [Related]
28. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J
Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321
[TBL] [Abstract][Full Text] [Related]
29. Independent influences of central fat and skeletal muscle lipids on insulin sensitivity.
Furler SM; Poynten AM; Kriketos AD; Lowy AJ; Ellis BA; Maclean EL; Courtenay BG; Kraegen EW; Campbell LV; Chisholm DJ
Obes Res; 2001 Sep; 9(9):535-43. PubMed ID: 11557834
[TBL] [Abstract][Full Text] [Related]
30. Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls.
Delpierre C; Bonnet E; Marion-Latard F; Aquilina C; Obadia M; Marchou B; Massip P; Perret B; Bernard J
J Clin Densitom; 2007; 10(4):376-80. PubMed ID: 17888698
[TBL] [Abstract][Full Text] [Related]
31. Calculating energy requirements for men with HIV/AIDS in the era of highly active antiretroviral therapy.
Batterham MJ; Morgan-Jones J; Greenop P; Garsia R; Gold J; Caterson I
Eur J Clin Nutr; 2003 Feb; 57(2):209-17. PubMed ID: 12571651
[TBL] [Abstract][Full Text] [Related]
32. A rosiglitazone-induced increase in adiponectin does not improve glucose metabolism in HIV-infected patients with overt lipoatrophy.
Blümer RM; van der Valk M; Ackermans M; Endert E; Serlie MJ; Reiss P; Sauerwein HP
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1097-104. PubMed ID: 19690066
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of safety and efficacy of rosiglitazone in the treatment of HIV-associated lipodystrophy syndrome.
Feldt T; Oette M; Kroidl A; Goebels K; Fritzen R; Kambergs J; Kappert G; Vogt C; Wettstein M; Häussinger D
Infection; 2006 Apr; 34(2):55-61. PubMed ID: 16703293
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal study of body composition of 101 HIV men with lipodystrophy: dual-energy X-ray criteria for lipodystrophy evolution.
Degris E; Delpierre C; Sommet A; Sire S; Lassoued S; Aquilina C; Marchou B; Massip P; Obadia M; Marion-Latard F; Bonnet E; Bernard J
J Clin Densitom; 2010; 13(2):237-44. PubMed ID: 20347366
[TBL] [Abstract][Full Text] [Related]
35. Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome.
Torriani M; Hadigan C; Jensen ME; Grinspoon S
J Appl Physiol (1985); 2003 Sep; 95(3):1005-10. PubMed ID: 12766180
[TBL] [Abstract][Full Text] [Related]
36. Hyperandrogenemia in human immunodeficiency virus-infected women with the lipodystrophy syndrome.
Hadigan C; Corcoran C; Piecuch S; Rodriguez W; Grinspoon S
J Clin Endocrinol Metab; 2000 Oct; 85(10):3544-50. PubMed ID: 11061499
[TBL] [Abstract][Full Text] [Related]
37. Hypermetabolism and altered substrate oxidation in HIV-infected patients with lipodystrophy.
Vassimon HS; de Paula FJ; Machado AA; Monteiro JP; Jordão AA
Nutrition; 2012 Sep; 28(9):912-6. PubMed ID: 22503533
[TBL] [Abstract][Full Text] [Related]
38. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women.
Hadigan C; Miller K; Corcoran C; Anderson E; Basgoz N; Grinspoon S
J Clin Endocrinol Metab; 1999 Jun; 84(6):1932-7. PubMed ID: 10372689
[TBL] [Abstract][Full Text] [Related]
39. Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function.
Andersen O; Haugaard SB; Andersen UB; Friis-Møller N; Storgaard H; Vølund A; Nielsen JO; Iversen J; Madsbad S
Metabolism; 2003 Oct; 52(10):1343-53. PubMed ID: 14564688
[TBL] [Abstract][Full Text] [Related]
40. Fat mass ratio: an objective tool to define lipodystrophy in hiv-infected patients under antiretroviral therapy.
Freitas P; Santos AC; Carvalho D; Pereira J; Marques R; Martinez E; Sarmento A; Medina JL
J Clin Densitom; 2010; 13(2):197-203. PubMed ID: 20347364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
